Rapaflo

Rapaflo (Silodosin) is an expensive drug used to treat enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH. It is not for use in women. It is slightly more popular than comparable drugs. There are currently no generic alternatives for Rapaflo. The most common version of Rapaflo is covered by 84% of insurance plans at a co-pay of $50.00-$72.50, however, some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from AbbVie, you can receive up to 12 months of medication at no cost to you if you are approved. You can also reapply as needed.